KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) FCF Margin: 2009-2024

Historic FCF Margin for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to 25.50%.

  • Pacira BioSciences' FCF Margin rose 217.00% to 31.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.33%, marking a year-over-year decrease of 1052.00%. This contributed to the annual value of 25.50% for FY2024, which is 484.00% up from last year.
  • According to the latest figures from FY2024, Pacira BioSciences' FCF Margin is 25.50%, which was up 23.40% from 20.67% recorded in FY2023.
  • Over the past 5 years, Pacira BioSciences' FCF Margin peaked at 25.50% during FY2024, and registered a low of 9.13% during FY2020.
  • Its 3-year average for FCF Margin is 21.15%, with a median of 20.67% in 2023.
  • Per our database at Business Quant, Pacira BioSciences' FCF Margin slumped by 521bps in 2020 and then soared by 561bps in 2021.
  • Pacira BioSciences' FCF Margin (Yearly) stood at 9.13% in 2020, then soared by 561bps to 14.75% in 2021, then soared by 253bps to 17.28% in 2022, then surged by 339bps to 20.67% in 2023, then surged by 484bps to 25.50% in 2024.